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ABSTRACT
Torque Teno Virus infection (TTV) was reported increase in human immunodeficiency virus (HIV)-infected
patients who are progressing toward AIDS (Acquired Immunodeficiency Syndrome). Toxoplasmosis is
considered one of the opportunistic infections for individuals with AIDS, and is also a major cause of morbidity
and mortality. However, there is no report about the presence of triple infection of TTV/Toxoplasma/HIV in
Indonesian HIV patients. Aim of this study is to determine the TTVToxoplasma/HIV infection status in HIV
patients in Moewardi General Hospital Surakarta, Indonesia. Blood samples from 51 HIV patients in Moewardi
General Hospital Surakarta were collected in November 2011. The blood samples were aliquoted and
fractionated. Plasma was used for IgM anti Toxoplasma and IgG anti Toxoplasma detection using ELISA.
The nucleic acid was extracted from all plasma samples, and then subjected for Torque Teno Virus DNA
detection using nested PCR assay. The positive results were confirmed by sequencing of the PCR products.
The IgM anti Toxoplasma and IgG anti Toxoplasma were positively detected in 23.5% (12/51) and 11.8% (6/
51) HIV patients, respectively. Torque Teno Virus DNA was detected in 25.5% (13/51) patients. Three HIV
patients co-infected with Torque Teno Virus were IgM anti Toxoplasma positive (5.9%, 3/51). This results
indicate the need for adequate management of HIV patients, especially in the incident of triple infection of
TTV/Toxoplasma/HIV.
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INTRODUCTION
Reports suggests the increase of Torque Teno Virus (TTV) replication in human immu-
nodeficiency virus (HIV)-infected patients who are progressing toward AIDS.  A high TTV
viral load was associated with a low CD4 cell count, indicating a potential role of the immune
system in controlling TTV replication (Thom & Petrik, 2007). Although it remains unclear the
role of the immune system in the natural of TTV infection, TTV may act as an opportunistic
pathogen (Pifferi et al., 2008; Maggi & Bendinelli, 2009). Toxoplasmosis already known as
an opportunistic infections in HIV/AIDS patients. Prior to antiretroviral therapy, toxoplasmo-
sis could induce cerebral lesion in AIDS patients (Nissapatorn, 2009). Moreover, cerebral
toxoplasmosis reported in Indonesia (Ganiem et al., 2013; Yunihastuti et al., 2005) indicating the
need to diagnose Toxoplasmosis in HIV-infected patients. The presence of triple infection of
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TTV/Toxoplasma/HIV as well as TTV in Indonesian HIV patients have not been published
yet.
MATERIALS AND METHODS
In November 2011, 51 blood samples were collected  from HIV patients in Moewardi
General Hospital Surakarta. The ethical approval was obtained from the institutional ethical
committee review boards of the Faculty of Medicine of Sebelas Maret University and Dr.
Moewardi General Hospital, Surakarta, Indonesia. Blood samples were fractionated,
aliquoted and kept frozen until further analysis. All procedures were conducted according to
the principles of the Declaration of Helsinki. The blood plasma was separated from whole
blood with EDTA and subsequently was subjected to the DRG T. gondii IgM Elisa Kit (DRG
International, Inc., Springfield, NJ) and DRG T. gondii IgG Elisa Kit (DRG International, Inc.)
following to the manufacturer’s instructions. All samples were tested in duplo. Viral nucleic
acid was extracted using the PureLink Viral RNA/DNA Kit (Invitrogen, Carlsbad, CA) ac-
cording to the manufacturer’s instructions. TTV-DNA was detected by nested PCR as de-
scribed previously (Irshad et al., 2008). Molecular detection was performed by PCR using
the Amplitaq Gold® 360 DNA Polymerase Kit (Invitrogen). Internal amplification controls
were included to exclude any false negative results. The corresponding positive controls and
one negative control (sterile water) were included in every assay. To prevent PCR contami-
nation, the reagent preparation, sample processing and nested PCR assays were performed
in rooms separate from those where the amplified products were analyzed. Aerosol-resis-
tant pipette tips were used throughout the assays. The PCR products were subjected to
electrophoresis in 2% agarose gels, which were stained with ethidium bromide and visual-
ized under ultraviolet illumination. The specificity was confirmed by sequencing the amplicons.
All samples were at least conducted two times.
RESULTS AND DISCUSSION
All HIV patients (31 women and 20 men) of Voluntary Counseling and Testing in Dr.
Moewardi General Hospital Surakarta Indonesia was participated in the study. The average
of age of the patients was 33.7 years (range 21-72 years). The mean of T Helper CD4+
absolute counts was 447 cells/ul. All respondents received antiretroviral therapies. The IgM
anti Toxoplasma and IgG anti Toxoplasma were positively detected on 23.5% (12/51) and
11.8% (6/51) HIV patients, respectively. By nested PCR, TTV DNA was detected in 25.5%
(13/51) patients. Three HIV patients (5.9%, 3/51) were co-infected with TTV and Toxoplasma.
All HIV patients co-infected with TTV were positive for IgM anti Toxoplasma. The TTV and
Toxoplasma infection in HIV patients may influence the HIV immunopathogenesis. TTV is
believed weaken the host’s defense mechanisms against other noxae and/or alter the way
the organism reacts to them, for example by keeping baseline levels of inflammation
elevated, so that the superimposed noxae deal with an already compromised, although
subclinical, state of affairs (Maggi & Bendinelli, 2009). Therefore, the presence of TTV in
HIV patients may increase the rapid spreading of Toxoplasma. Toxoplasma itself has ability
to decrease the production of Interleukin-12 and Interferon Gamma, and immunomodulate
the host immune response (Laliberté & Carruthers, 2008). However, the mechanism on how
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TTV and or Toxoplasma influence the host immune response, and wether any influence in
pathogenesis, especially in patients infected with HIV remains unclear.  In fact, our group
research is working on this issues.
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